Submitted by Anonymous (not verified) on 15 July 2025 - 2:32
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 27, Status: Authorised